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We aimed at investigating the effect of carbon dots on the BALB/c mice immune system. Mice were respectively
treated with different doses of carbon dots and saline. At 1 and 9 days after intravenous administration of carbon
dots, splenocyte proliferation, subpopulation of the peripheral lymphocytes, and induction of primary immune
responses in mice were investigated. The results showed that high dose of carbon dots could promote the
percentages of CD3+ and interferon-γ (IFN-γ) secretion and decrease the proportions of CD4+/CD8+ on the first
day after administration. At 9 days post exposure, the proliferation of splenocytes had a significant increase. IFN-γ
secretion and proportions of CD3+/CD19+ were also found to have an obvious promotion, and both the
percentages of CD4+ and CD8+ T lymphocytes were raised, whereas the expression of cytokines made little
change in the treated groups, except for IL-12 which had a slight increase in the 50-mg/kg group. The weight
coefficients and histological analysis of the spleen and thymus of the treated mice exerted fewer differences
compared with those from the control mice. It suggests that carbon dots could influence the immune functions
of normal BALB/c mice by inducing Th1 and Tc responses and that these effects were not enough to induce the
morphological change of the immune organs.
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Two-photon-fluorescent nanoparticles, primarily quantum
dots (QDs), have recently attracted much attention for
their many promising applications, especially in the field
of biomedical imaging [1,2] and detection [3-5]. These
QDs are considered as being more advantageous over
conventional organic dyes in terms of optical brightness,
photostability, and resistance to metabolic degradation
[6]. However, heavy metals as the essential elements in
QDs have prompted serious health and environmental
concerns [7]. Therefore, the search for benign alterna-
tives has become increasingly important and urgent.
Sun et al. discovered that nanosized pure carbon par-
ticles may be surface-passivated to exhibit bright
photoluminescence in the visible and near-infrared
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in any medium, provided the original work is pnanoparticles, abbreviated as carbon dots, were found
to be physicochemically and photochemically stable and
non-blinking and exhibited very high two-photon ab-
sorption cross sections [9,10]. Carbon dots as a new
class of QD-like fluorescent nanomaterials have been
widely explored in biological applications and beyond
[9-12].
Carbon has generally not been considered as a toxic
element; however, there are growing evidence and contro-
versies concerning the toxicity of fullerenes and carbon
nanotubes [13-15]. For special material configurations and
structures found in carbon dots, it is essential to evaluate
their biocompatibility in vitro and in vivo. In this contribu-
tion, we investigated the effects of carbon dots on the im-
mune function of normal BALB/c mice to elucidate the
interactions between carbon dots and the immune system
and to explore more theoretic evidence for the application
of carbon dots in the field of medical diagnosis and
biotherapeutics.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Experimental agents
Experimental agents were sourced from the following lo-
cations: raw soot (Jixi Kaiwen Hu Limited Co., Jixi, Anhui,
China); RPMI-1640 (HyClone, Thermo Scientific Co.,
Waltham, MA, USA); anti-CD3 (peridinin-chlorophyll
protein complex (Percp)), anti-CD19 (adenomatous polyp-
osis coli (APC)), anti-CD4 (phycoerythrin (PE)), anti-CD8
(fluorescein isothiocyanate (FITC)) (Becton Dikinson
Company, Franklin Lakes, NJ, USA); fetal bovine serum
(FBS; HyClone, Thermo Scientific Co. USA); bicinchoninic
acid (BCA) protein assay kit (Nanjing Keygen Biotech.
Co., Ltd, China); interleukin-4 (IL-4) and interferon-γ
(IFN-γ) enzyme-linked immunosorbent assay (ELISA) kit
(Neobioscience Technology Co., Ltd, Shenzhen, China);
concanavalin A (ConA), lipopolysaccharide (LPS) (Sigma-
Aldrich Co., St Louis, MO, USA); anti-TNF-α, anti-IL-12,
anti-IFN-γ, anti-IL-4 (Santa Cruz Biotechnology, Inc,
Santa Cruz, CA, USA); rabbit anti-β-actin (Beijing Biosyn-
thesis Biotechnology Co., Ltd, Beijing, China).Synthesis and characterization of carbon dots
Carbon dots were prepared using the improved nitric acid
oxidation method. In the typical experiment, 0.5 g of raw
soot was dispersed ultrasonically in acetone solution for
30 min and then centrifugated and dried under vacuum at
80°C. Subsequently, the cleaned soot was refluxed in 25-
ml 5 M HNO3 at 120°C for 14 h. The black suspension
was cooled down to room temperature and centrifugated
at 3,000 rpm for 10 min to remove the unreacted precipi-
tate. The light brown solution was neutralized by Na2CO3
and then dialyzed against Millipore pure water (Billerica,
MA, USA) for 3 days to remove the salt of sodium
through a dialysis membrane with an MW cutoff value of
1,000, affording purified carbon nanoparticles. After that,
further size separation of carbon nanoparticles was
performed by stepwise ultrafiltration with NMWL values
of 5,000 and 3,000 ultrafiltration membranes using a
Millipore stirred ultrafiltration cell. Finally, the carbon
dots were dialyzed with an MCO of 3,000 dialysis
membrane.
Atomic force microscopy (AFM) images of carbon
dots were taken on a MultiMode Nanoscope III, a scan-
ning probe microscopy system (Veeco, Plainview, NY,
USA). The samples for AFM were prepared by dropping
an aqueous suspension (0.01 mg/ml) of carbon dots on
freshly cleaved mica surface and dried under vacuum at
80°C. UV-visible (vis) spectra were measured at 20°C
with a Shimadzu UV-2450 UV–vis spectrophotometer
(Kyoto, Japan) equipped with a 10-mm quartz cell,
where the light path length was 1 cm. Fluorescence
spectra were recorded on a HITACHI H FL-4600 spec-
trofluorimeter (Tokyo Japan).Animal injection, weight measurements, and sample
collection
Female BALB/c mice (approximately 18 to 22 g), obtained
from the Center of Laboratory Animals of Academy of
Military Medical Sciences in compliance with the Institu-
tional Animal Care and Use Program Guidelines, were
given food and water ad libitum and housed in a 12-h/12-
h light/dark cycle. After acclimation, the mice were ran-
domly divided into eight experimental groups, each
consisting of ten mice. Before intravenous administration
to mice, the carbon dots were well sonicated and diluted
in physiologic saline. The six groups for administration
were injected in the tail vein with carbon dots at 2, 10,
and 50 mg/kg (each dose is treated to two groups), and
the last two groups were treated with saline as control. At
1 and 9 days post exposure, body weights of the mice were
measured. Thereafter, the blood samples were collected
and the mice were sacrificed. Spleen and thymus samples
were surgically removed immediately and weighed in a
sterile hood. One part of organ samples was cut off and
fixed in 4% formaldehyde solution, and the other parts
were used for immunological assays. The weight coeffi-
cients of the spleen or thymus (%) = spleen or thymus
weight (g)/mice body weight (g) × 100. Blood samples
obtained from the mice were centrifuged (12,000 rpm) for
10 min at 4°C to separate serum and blood cells. The
serum was stored at −80°C for determination of cytokines.
For histopathological observation, the thin-sectioned tis-
sue specimens were stained with hematoxylin and eosin
and examined under light microscopy.
Lymphocyte proliferation assay
Single-cell suspensions were prepared from the spleens in
RPMI-1640 medium. Firstly, fresh spleens (n = 5 per
group) were put into 5 ml of RPMI-1640 before grinding
the organs with a syringe core on the nylon net (200
meshes) to prepare crude splenocyte suspension. The sus-
pension was freed from debris by centrifugation at 1,000
rpm for 10 min at 4°C. The remaining splenocyte suspen-
sion was resuspended with 2-ml Tris-NH4Cl buffer solu-
tion (the proportion of 0.16 mol/l NH4Cl and 0.17 mol/l
Tris was 9:1, pH 7.2) to lyse red blood cells. After 5 min of
treatment, the splenocyte suspension was replenished to 5
ml with RPMI-1640 medium and then centrifugated at
1,000 rpm for 10 min at 4°C. The precipitated splenocytes
of each group were washed twice and adjusted to 5 × 106
cells/ml with 10% FBS RPMI-1640. The splenocyte sus-
pension of each group was planted in a 96-well flat bot-
tom plate in 100-μl aliquots. The cells were respectively
introduced by the T cell mitogen (ConA, 4 μg/ml, 100 μl
per well, five wells for each group) and the B cell mitogen
(LPS, 20 μg/ml, 100 μl per well, five wells for each group).
Meanwhile, the wells (saline group) receiving complete
RPMI-1640 were regarded as control. The cells were
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(NAPCO 5410, Precision Scientific Instruments, Buffalo,
NY, USA) containing 5% CO2 and then cultured at 37°C
in the dark for 4 h following the administration of 20 μl
MTT (0.5 mg/ml) into each well. After the removal of the
suspension, 200 μl of 10% SDS was added to each well to
dissolve the formazan, and then cells were cultured for
another 12 h under identical conditions. Lymphocyte pro-
liferation activity was detected by absorbance at a wave-
length of 570 nm using a microplate reader (Thermo
Fisher Scientific Inc., Waltham, MA, USA).
Analysis of lymphocyte subset
Phenotypic analyses of lymphocytes were performed
using a flow cytometer. The splenocytes were incubated
with monoclonal antibodies against CD3, CD19, CD4,
and CD8 conjugated with different fluorochromes (anti-
CD3 (Percp), anti-CD19 (APC), anti-CD4 (PE), and anti-
CD8 (FITC)) for 30 min in the dark and then washed
three times, resuspended in FACS permeabilizing solu-
tion before determination. At least 10,000 cells were an-
alyzed for each Mab staining using a FACScan flow
cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).
Detection of cytokines
Thymocyte suspension was prepared from thymocytes in
the RPMI-1640 medium. The suspension of thymocyte
and splenocyte was adjusted to 1 × 107 and 2 × 107 cells/
ml, respectively, and planted into the 24-well flat-bottom
plate (0.5 ml per well). ConA was added to the final con-
centration of 5 μg/ml to introduce cytokine secretion. The
cells were cultured for 48 h at 37°C in a humidified incu-
bator containing 5% CO2 at 37°C. The supernatant of each
well was collected for cytokine analysis. IL-4 and IFN-γ
ELISA kits were used. Briefly, 50-μl samples or standard
control were mixed with 50-μl assay diluents and incu-
bated at 37°C for 90 min. After being washed five times,
100-μl antibody-labeled biotin was added to each well.
The plate was incubated for 60 min. Following five times
of rinsing, a 100-μl substrate solution was added to each
well and incubated for 30 min. Finally, a 100-μl stop solu-
tion was added to each well, and the colored reaction
product was measured at 450 nm on a microplate reader
(Thermo Fisher Scientific Inc.).
The expression level of cytokine analysis by Western blot
Fresh spleens of mouse in each group were stored in ice-
cold tubes, and then the total proteins were extracted
from the organs. The protein concentration was ana-
lyzed using BCA protein assay kit. The proteins in the
spleen extracts were separated by 10% SDS-PAGE and
electrophoretically transferred onto a polyvinlidene
difluoride membrane (Bio-Rad, Hercules, CA, USA).
The membranes were blocked with 5% nonfat milk inTBS containing 0.1% Tween 20 at 37°C for 2 h followed
by incubation overnight at 4°C with antibodies against
IL-12, IFN-γ, IL-4, and TNF-α. β-Actin was taken as the
reference protein. The membranes were washed with
TBS containing 0.1% Tween 20 and probed with horse-
radish peroxidase-labeled goat anti-rabbit or anti-mouse
IgG. The proteins were detected with enhanced chemi-
luminescence imaging.
Statistical analysis
Data were analyzed using the Statistical Package for
Social Science (version 19.0; SPSS Inc., IBM, Armonk,
NY, USA). The significant difference between groups




The characteristic of carbon dots
As shown in Figure 1, the UV–vis absorption spectra of
carbon dots and photoluminescence (PL) emission spec-
tra excited by various incident lights are shown in
Figure 1a,b, respectively. At an excitation wavelength of
340 nm, a strong emission peak at about 430 nm was ob-
served in the PL emission spectrum of carbon dots.
When the excitation wavelength increased from 320 to
400 nm, the emission peak also shifted with a maxima
redshift of about 10 nm. The AFM height images and
section analysis demonstrated that the diameters of the
carbon dots were 3 to 8 nm and the sizes of nanoparticles
were spherical and uniform (Figure 1c,d). Due to the ex-
istence of carboxyl and hydroxyl groups on the surface of
carbon dots, the carbon dots were found to dissolve eas-
ily in water and polarity organic solvent (such as ethanol,
acetone) but were insolubilized in apolar organic solvent.
Organ weight and histological analysis
BALB/c mice treated with carbon dots appeared healthy,
and their body weight gain patterns were similar to
those of the control group. At 1 day post exposure, both
immune organ (spleens and thymuses) weight coeffi-
cients showed no difference between the experimental
group and the control group (Table 1). As shown in
Figure 2, the structures of the immune organs from the
exposed mice were normal. There were no necrosis and
hydropic degeneration observed in the splenetic and
thymic sections from the exposed mice. On the ninth
day after administration, little difference was also found
in the weight coefficients and the pathological analysis
of immune organs from the carbon dot-treated mice
compared with those of the saline control (Table 1;
Figure 2). It suggested that carbon dots caused little
morphological and histopathological changes in the
spleen and thymus.
Figure 1 UV–vis absorption, PL emission spectra, AFM height images, and section analysis of carbon dots. (a) UV–vis absorption of
carbon dots-NH2. (b) Photoluminescence emission spectra of carbon dots with progressively excitation wavelength from 320 to 400 nm in 10-nm
increment; inset is the solution illuminated with a UV lamp, (c) AFM height images of carbon dots. (d) The section analysis of carbon dots.
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On the first day after administration, both B and T
lymphocyte proliferations were measured, and the result
indicated that carbon dot treatment could not influence
the spleen B and T lymphocyte proliferations. However,
both T and B lymphocytes were found to have increased
and proliferated in the carbon dot-treated groups com-
pared with the saline control group on the ninth day
post exposure (P < 0.05; Figure 3). Furthermore, the pro-
liferative capacity of lymphocytes was dependent on the
dose of carbon dots. The 50-mg/kg administration of
carbon dots had a more significant effect on the T
lymphocyte proliferation than the 2-mg/kg administra-
tion (P < 0.05). The B lymphocyte proliferation in mice
treated with 50 mg/kg of carbon dots increasedTable 1 Effects of carbon dots on spleen and thymus weight
Groups Spleen coefficient
1 day 9 days
Saline 0.3616 ± 0.0027 0.9817 ± 0.1
Carbon dots
2 mg/kg 0.3711 ± 0.0128* 0.8617 ± 0.2
10 mg/kg 0.4020 ± 0.0537* 0.8443 ± 0.0
50 mg/kg 0.4469 ± 0.0846* 0.9927 ± 0.3
The data are presented as mean ± standard deviations, n = 5. *P > 0.05 compared
way ANOVA using SPSS19.0.significantly compared with the other two groups treated
with carbon dots (P < 0.05; Figure 3).
The proportions of lymphocyte subsets
The percentage of CD3+ and CD19+ represented the rela-
tive quantities of T and B lymphocytes, and the percentage
of CD4+ and CD8+ explained the proportion of helper T
(Th) cells and cytotoxic T (Tc) cells, respectively. Com-
pared with the saline group, only the 50-mg/kg group had
a significant percentage of CD19+ (P < 0.05; Table 2); all
of the three carbon dot-treated groups were found to have
a decrease in the ratio of CD4+/CD8+ versus the control
group on the first day after administration (P < 0.01;
Table 3). At 9 days post exposure, a significant increase of
the percentage of CD3+ was noticed in the three carboncoefficient of BALB/c mice
Thymus coefficient
1 day 9 days
343 0.2305 ± 0.0148 0.2598 ± 0.0955
637* 0.2092 ± 0.0502* 0.2707 ± 0.0687*
871* 0.2057 ± 0.0328* 0.2793 ± 0.0215*
637* 0.1886 ± 0.0095* 0.2653 ± 0.0398*
with the saline group (control). Significant difference was calculated by one-
Figure 2 Histopathological analyses of spleen and thymus of mice. Mice were injected in the caudal vein with different doses of carbon
dots. The samples of spleen and thymus were separated for histopathological analysis. There were no necrosis and hydropic degeneration
observed in the splenetic and thymic sections in carbon dot-treated mice both on the first and ninth days post exposure.
Gao et al. Nanoscale Research Letters 2013, 8:276 Page 5 of 8
http://www.nanoscalereslett.com/content/8/1/276dot-treated groups versus the control (P < 0.01), and the
increase of CD19+ percentage was observed in the 2-
and 10-mg/kg groups versus the control (P < 0.01;
Table 4). Furthermore, the ratio of CD3+/CD19+ had an
evident increase in all the three carbon dot-treated
groups versus the control (P < 0.01 for 2 and 50 mg/kg;
P < 0.05 for 10 mg/kg; Table 4). The percentage of
CD19+ in the 10-mg/kg administration groups was
higher than that in the other two carbon dot-treated
groups (P < 0.01; Table 4). Compared with the saline
group, the proportion of both CD4+ and CD8+ T
lymphocyte subsets was increased in drug-treated
groups versus the control (P < 0.01; Table 5). However,
administration of carbon dots decreased the ratio of
CD4+/CD8+, especially for the 2-mg/kg group versus
the control (P < 0.05; Table 5), whereas there wasDay 1
Figure 3 Influence of carbon dots on splenocyte proliferation of BALB
doses of carbon dots. Spleen samples were separated to prepare splenocyt
introduced by ConA, and B lymphocytes were introduced by LPS. Data are
with saline group; #P < 0.01 compared with lower dose carbon dot-treated
using SPSS19.0.no difference in the percentage of CD4+ and CD8+
between the administration groups (P > 0.05; Table 5).
Influence on cytokine production
Cytokines IFN-γ and IL-4 levels in sera of mice were not
detected in the preliminary experiment (data were not
shown). Therefore, splenocyte and thymocyte suspen-
sions were used to assay the production of cytokines. At
1 day post treatment, the secretion of IFN-γ promoted
significantly in the 50-mg/kg group (P < 0.01; Figure 4),
and a slightly increased level of IFN-γ was also found in
the other two treated groups versus the saline group
(P > 0.05; Figure 4). On the ninth day after administra-
tion, the result of cytokine assay indicated that carbon
dot treatment could significantly increase the secretion
of IFN-γ and displayed as dose dependent (P < 0.01, forDay 9
/c mice. BALB/c mice were injected in the caudal vein with different
es at 1 or 9 days after the administration. T lymphocytes were
presented as means ± standard deviations, n = 5. *P < 0.01 compared
group. Significant difference was calculated by one-way ANOVA
Table 4 Effects of carbon dots on percentage of CD3+ and
CD19+ lymphocytes in spleen of BALB/c mice
Groups CD3+ (%) CD19+ (%) CD3+/CD19+
Saline 18.00 ± 1.40 28.74 ± 1.14 0.63 ± 0.02
Carbon dots
2 mg/kg 26.48 ± 0.52**↑ 33.88 ± 0.56**↑ 0.78 ± 0.02**↑
10 mg/kg 25.50 ± 0.36**↑ 35.95 ± 0.94**↑ 0.71 ± 0.03*↑
50 mg/kg 26.68 ± 0.57**↑ 29.87 ± 1.07 0.89 ± 0.05**↑
The effects were recorded 9 days after administration. Data are presented as
mean ± standard deviations, n = 5. *P < 0.05 and **P < 0.01 compared with
the saline group (control). Significant difference was calculated by one-way
ANOVA using SPSS19.0.
Table 2 Effects of carbon dots on percentage of CD3+ and
CD19+ lymphocytes in spleen of BALB/c mice
Groups CD3+ (%) CD19+ (%) CD3+/CD19+
Saline 36.01 ± 1.62 58.01 ± 1.55 0.62 ± 0.04
Carbon dots
2 mg/kg 37.44 ± 0.32 57.44 ± 0.55 0.65 ± 0.01
10 mg/kg 35.12 ± 0.39 58.09 ± 0.32 0.60 ± 0.01
50 mg/kg 36.97 ± 1.81**↑ 55.81 ± 0.73*↓ 0.70 ± 0.02**↑
The effects were recorded 1 day after administration. The data are presented
as mean ± standard deviations, n = 5. *P < 0.05 and **P < 0.01 compared with
the saline group (control). Significant difference was calculated by one-way
ANOVA using SPSS19.0.
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control; Figure 4). There was a significant difference in
the production of IFN-γ between the carbon dot admin-
istration groups (P < 0.01). However, the secretion of
IL-4 in thymocyte suspensions was not detected in all
experimental groups both at 1 and 9 days after adminis-
tration (data were not presented).
Effect on the expression level of the cytokines
Cytokines play an important role in cellular immunity.
To clarify the possible mechanism of the effects of car-
bon dots to the immune system in mice, the expression
levels of IL-12, IFN-γ, IL-4, and TNF-α in the spleens of
mice treated with carbon dots were detected by Western
blot. Compared with the saline group, the expression
levels of four cytokines did not have any obvious change
in the three carbon dot administration groups both on
the first and ninth days after administration (Figure 5).
Discussion
B and T lymphocytes, which play an important role in
the process of adaptive immunity, are the central cells of
the immune system. Both of them are resting cells in the
G0 phase of the cell cycle when they have not interacted
with antigens. Once stimulated by certain mitogens, these
cells would be activated into the cell cycle (by pro-
gressing from G0 into G1 and subsequently into S, G2,
and M) and promoted to proliferate and differentiate.Table 3 Effects of carbon dots on T lymphocyte subsets
in spleen of BALB/c mice
Groups CD4+ (%) CD8+ (%) CD4+/CD8+
Saline 25.97 ± 0.65 9.94 ± 1.01 2.63 ± 0.21
Carbon dots
2 mg/kg 24.95 ± 0.20 12.54 ± 0.26**↑ 1.99 ± 0.04**↓
10 mg/kg 24.31 ± 0.41**↓ 11.00 ± 0.14 2.21 ± 0.05**↓
50 mg/kg 26.51 ± 0.44 12.75 ± 0.12**↑ 2.08 ± 0.04**↓
The effects were recorded 1 day after administration. Data are presented as
mean ± standard deviations, n = 5. **P < 0.01 compared with the saline group
(control). Significant difference was calculated by one-way ANOVA
using SPSS19.0.Thus, the proliferation of lymphocytes following expos-
ure to mitogenic stimuli is an important methodology
for the assessment of cell-mediated immunity [16]. In
the present study, we investigated the influence of car-
bon dots on lymphoproliferation in the spleen following
exposure to the B cell mitogen (LPS) and T cell mitogen
(ConA). As the results showed, splenic lymphocytes had
little increase in proliferation in the carbon dot groups
at 1 day post exposure. However, both B and T lympho-
cyte proliferation in treated groups increased signifi-
cantly in a dose-dependent manner on the ninth day
after administration.
B and T lymphocytes can be distinguished by the pres-
ence of either CD3 or CD19 membrane glycoproteins on
their surfaces; thus, the number of T and B lymphocytes
can be approximated by assaying the percentage of CD3+
and CD19+. Also, the subsets of T lymphocytes can be
distinguished by the presence of CD4 and CD8. At 1 day
after administration, the percentage of CD3+ and the ra-
tio of CD3+/CD19+ have an evident increase only in the
50-mg/kg group. Nevertheless, the three administered
groups were detected an obvious increase in the percent-
age of CD3+ and the ratio of CD3+/CD19+ without a
dose-dependent relationship. The result of higher ratios
of CD3+/CD19+ in all of the three carbon dot-treated
groups indicated that the proliferation of T lymphocytes
was more significant than that of B lymphocytes in per-
ipheral lymphocytes under the administration of carbonTable 5 Effects of carbon dots on T lymphocyte subsets
in spleen of BALB/c mice
Groups CD4+ (%) CD8+ (%) CD4+/CD8+
Saline 10.85 ± 1.15 5.47 ± 0.62 1.99 ± 0.17
Carbon dots
2 mg/kg 16.05 ± 0.24**↑ 9.89 ± 0.40**↑ 1.63 ± 0.09*↓
10 mg/kg 15.77 ± 0.59**↑ 9.16 ± 0.28**↑ 1.73 ± 0.12
50 mg/kg 16.56 ± 0.28**↑ 9.65 ± 0.44**↑ 1.72 ± 0.05
The effects were recorded 9 days after administration. The data are presented
as mean ± standard deviations, n = 5. *P < 0.05 and **P < 0.01 compared with
the saline group (control). Significant difference was calculated by one-way
ANOVA using SPSS19.0.
Day 1 Day 9
Figure 4 Concentration of cytokine INF-γ in splenocyte suspension. The levels of INF-γ were measured quantitatively using IFN-γ ELISA
kit. Data are presented as means ± standard deviations, n = 5. *P < 0.01 compared with saline control. Significant difference was calculated by
one-way ANOVA using SPSS19.0.
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proliferation.
The two major subpopulations of T lymphocytes are Th
cells and Tc cells. In general, CD4+ cells act as helper cells
and CD8+ cells act as cytotoxic cells. The Th cells can also
be defined as two major functional subpopulations, Th1
and Th2 cells. The Th1 response produces cytokines
(IFN-γ, TNF-β, etc.) that support inflammation and acti-
vate mainly certain T cells and macrophages, whereas
the Th2 response secretes cytokines (IL-4, IL-5, etc.)
which activate mainly B cells and immune responses
that depend upon antibodies [17,18]. The Tc cells can
recognize antigens combined with class I MHC in the
presence of appropriate cytokines (IFN-γ) and give rise
to cytotoxic T cells, which display cytotoxic ability.
Several studies have addressed the influence of nano-
particles on Th1 and Th2 responses. It is reported that
some small engineered nanoparticles such as 80- and
100-nm nanoemulsions, 95- and 112-nm PEG-PHDA
nanoparticles, and 123-nm dendrosome, could induce
the Th1 response [19]. We observed that carbon dots
could promote the percentage of CD8+ and decreaseDay 1
Figure 5 IL-12, IFN-γ, IL-4, and TNF-α in spleens of mice treated with
cytokines. Compared with the saline group, the expression levels of four cy
dot-treated groups both on the first and ninth days post exposure.the ration of CD4+/CD8+. Nevertheless, both the per-
centages of CD8+ and CD4+ had a significant increase
without a dose-dependent relationship at 9 days after
administration, and the ration of CD4+/CD8+ de-
creased only in the 2-mg/kg group. The levels of IFN-γ
also had a significant increase in the carbon dot-treated
groups. From these results, we presume that the main
modulator pathway of carbon dots was to activate the
Th1 cells. The Th1 cells secreted IFN-γ cytokines,
which played an important role in the activation of the
proliferation and differentiation of the Tc cells (CD8+ T
cell), and then the percentage of CD8+ increased, and
the ratios of CD4+/CD8+ declined. The IFN-γ cytokines
could also be produced by Tc cells, which were dedi-
cated to the increase of the levels of IFN-γ. On the other
hand, the production of IL-4 cytokines was hardly to be
detected both in the blood serum and the supernatant
of induced lymphocytes, indicating that carbon dots, at
the treated dose, could not induce the response of Th2
cells, which play an important role in the activation
process of humoral immunity. The results of Western
blot did not show any changes in the cytokine levels inDay 9
carbon dots. Western blot was used to measure the levels of
tokines did not have any obvious change in the three carbon
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with the result of the weight coefficients and histological
analysis of the spleen and thymus.
Conclusions
A delicate balance between innate and adaptive immunity
is required for efficient functioning of the immune system.
This balance is important in cancer immunity, immune
response against pathogens, and avoiding hypersensitivity
reactions [20]. In this study, we have demonstrated that
carbon dots could adjust the immune function of BALB/c
mice by inducing Th1 and Tc responses. However, these
effects were not enough to induce the morphological
change of immune organs. The mechanism by which car-
bon dots modulate the immune system remains unclear.
More systematic and profound studies are needed, and
the pertinent testing guidelines for immunological evalu-
ation of nanoparticles need to be formulated quickly.
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